Investors Not Exactly Stoked About New York’s MMJ Market

Companies spent millions of dollars combined trying to win one of New York’s five coveted medical marijuana business licenses, but investors aren’t exactly bullish on the market’s potential now that permits have been awarded.

Many institutional investors are concerned with state limits on the MMJ industry in New York, expressing concerns that each licensed company can only have four dispensaries statewide (for a grand total of 20 storefronts) and that the qualifying medical conditions list is relatively short.

“We believe it’s going to be an extremely limited market,” the CEO of Invest in Cannabis told the New York Business Journal.

The investment firm has 24 companies across the nation in its portfolio and is based in New York City. Yet the CEO sees the state’s market potential as “pretty small because of… the amount of customers that actually have the potential to enter the market.”

Other concerns include a potential lack of physicians willing to write recommendations for MMJ and the fact that there are better opportunities in other markets.

Still, some New York observers are optimistic, the Journal reported.

“I think it will start small and slow, but once it takes shape, it’s going to be one of the biggest markets,” one entrepreneur said.

One comment on “Investors Not Exactly Stoked About New York’s MMJ Market
  1. Brett Roper on

    The evolution of the NY Cannabis Marketplace will be one to watch considering how very restrictive the law currently is relative to product deployment and pharmacist oversight of dispensing. I doubt that there will be any immediate impact on those accessing products and flower related material on the gray/black market due to the lack of a traditional, more viable medical products channel similar to those allowable in other states adopting less restrictive medical based regulations. I am also curious to see how the State will regulate pricing and how the investment capital required to enter this marketplace will find any reasonable return potential for years to come. I also believe that the real winners in this prospective marketplace may well end up being those other 38 applicants that did not succeed in securing one of the initial five spots but that will be well prepared for the next deployment round???

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *